SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-06-000303
Filing Date
2006-03-31
Accepted
2006-03-31 17:51:07
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a19096e10vk.htm 10-K 1353834
2 EXHIBIT 31.1 a19096exv31w1.htm EX-31.1 6103
3 EXHIBIT 31.2 a19096exv31w2.htm EX-31.2 6100
4 EXHIBIT 32.1 a19096exv32w1.htm EX-32.1 3537
5 EXHIBIT 32.2 a19096exv32w2.htm EX-32.2 3531
6 GRAPHIC a19096a1909601.gif GRAPHIC 5343
  Complete submission text file 0000936392-06-000303.txt   1382037
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20720 | Film No.: 06730519
SIC: 2834 Pharmaceutical Preparations